242 results on '"Fang, Yueh-Fu"'
Search Results
2. Clinical manifestations and outcomes of fungus-associated asthma: A multi-institution database study in Taiwan
3. The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis
4. Real-world insights from comprehensive genomic profiling across multiple cancer types.
5. Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis
6. Real-World Insights from Comprehensive Genomic Profiling Across Multiple Cancer Types: An Experience of Two Medical Centers in the National Biobank Consortium of Taiwan (NBCT) Project
7. Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC
8. PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.
9. A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed
10. Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib
11. Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells
12. Data from Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast Cancer
13. Data Supplement from Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast Cancer
14. One-year mortality among hospital survivors of cholinesterase inhibitor poisoning based on Taiwan National Health Insurance Research Database from 2003 to 2012
15. The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR ‐mutated non–small cell lung cancer
16. Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommonEGFRmutations: Real‐world data from Taiwan
17. Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma
18. The Impact of Higher Protein Intake in Patients with Prolonged Mechanical Ventilation
19. Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients
20. Clinical outcomes and prognostic factors of bronchiectasis rheumatoid overlap syndrome: A multi-institution cohort study
21. Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study
22. Platelet Activation in High D-Dimer Plasma Plays a Role in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Mutant Lung Adenocarcinoma
23. Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients
24. Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan
25. Epidermal Growth Factor Receptor Potentiates MCM7-Mediated DNA Replication through Tyrosine Phosphorylation of Lyn Kinase in Human Cancers
26. sj-docx-1-tam-10.1177_17588359221113278 – Supplemental material for Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study
27. sj-docx-2-tar-10.1177_17534666221132731 – Supplemental material for Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations
28. The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer.
29. Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.
30. Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan.
31. Multimodality Treatment and Long-Term Follow–Up of the Primary Pulmonary Lymphoepithelioma-Like Carcinoma
32. Real-world Afatinib Outcomes in Advanced Non–small Cell Lung Cancer Harboring EGFR Mutations
33. Comparative Effectiveness and Safety of Standard-Dose and Low-Dose Pembrolizumab in Patients with Non-Small-Cell Lung Cancer: A Multi-Institutional Cohort Study in Taiwan
34. Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI
35. Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation
36. Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations
37. Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study
38. Afatinib and osimertinib in lung adenocarcinoma harboredEGFRT751_I759delinsS mutation: A case report
39. Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation
40. Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
41. Before and after Endovascular Aortic Repair in the Same Patients with Aortic Dissection: A Cohort Study of Four-Dimensional Phase-Contrast Magnetic Resonance Imaging
42. Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study
43. Subsequent Chemotherapy Improves Survival Outcome in Advanced Non–Small-Cell Lung Cancer With Acquired Tyrosine Kinase Inhibitor Resistance
44. Prognostic Factors in Lung Adenocarcinoma with Bone Metastasis Treated with EGFR-TKIs
45. A Novel Tool for a Challenging Disease: Stasis Leg Ulcers Assessed Using QFlow in Triggered Angiography Noncontrast Enhanced Magnetic Resonance Imaging
46. Superficial Venous Reflux Intervention Guided by Triggered Angiography Non-Contrast-Enhanced Sequence Magnetic Resonance Imaging: Different QFlow Pattern from Health Controls
47. sj-docx-1-tam-10.1177_17588359211035710 – Supplemental material for First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer
48. Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients
49. Increased epidermal growth factor receptor ( EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: A chromogenic in situ hybridization study of 182 patients
50. Topical dicloxacillin solution wash for papulopustular eruptions and purpuric drug eruptions due to epidermal growth factor inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.